Artículos del autor

solaci

Acute coronary syndromes

Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus after ST-Segment Elevation Acute Coronary Syndrome

The incidence of left ventricular thrombosis (LVT) after anterior ST-segment elevation myocardial infarction (STEMI) ranges from 4%...
solaci -
Institutional News

Rewatch our Webinar on Training Opportunities in Clinical and Basic Research in Latin America. Timb to Climb

Training Opportunities in Clinical and Basic Research in Latin America.
solaci -
Institutional News

Deadline Extended! Send Your Case Before Friday 13th

Clinical Case Contest for Young Interventionists In order to give opportunities to all professionals in the region, we...
solaci -
Coronary disease

IVUS-Guided Coronary Angioplasty: Promising Results at 3-Year Follow-Up

Intravascular ultrasound (IVUS) to guide drug-eluting stent (DES) implantation has been evaluated in several studies. Two randomized...
solaci -
Coronary disease

Passive Leg Raise: An Indispensable Maneuver in the Study of Heart Failure with Preserved Ejection Fraction

Heart failure (HF) with preserved ejection fraction (HFpEF) accounts for at least 50% of the HF population,...
solaci -
Fellow’s Corner

Fellow’s Corner Invitation. Submit your case and let’s keep learning together

Dear LATAM Fellows: We would like to tell you the Fellow's Corner is coming back this year (FC). This is...
solaci -
Chronic Ischemic cardiopathy

In Multivessel Disease, When Should Renal Impairment Be Considered?

Cardiovascular disease is one of the main causes of morbidity and mortality in patients with advanced chronic...
solaci -
Antiplatelet

Should Aspirin Be the Standard of Secondary Prevention of MACE?

Much has been published recently on short term dual antiplatelet therapy (DAPT) both in acute (ACS) and...
solaci -